A Landscape of Pharmacogenomic Interactions in CancerFrancesco Iorio, Mathew J. Garnett, Syd Barthorpe et al.|Cell|2016Cited by 2.3k
BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanismJiaji G. Chen, Guang Yang, Xia Liu et al.|Blood|2018Cited by 84
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomasManit Munshi, Guang Yang, Xia Liu et al.|Blood Cancer Journal|2020Cited by 45
RSK1 Activation Promotes Invasion in Nodular MelanomaAmel Salhi, Iman Osman, Joshua A. Farhadian et al.|American Journal Of Pathology|2015Cited by 32